Genovis AB: Half-Yearly Report January-June 2023
https://mb.cision.com/Main/1712/3820614/2247306.pdf
https://news.cision.com/genovis-ab/r/half-yearly-report-january-june-2023,c3820614
Continued strong growth in both enzyme and antibody business
January - June 2023
Net sales totaled SEK 100,739 (53,667) thousand, with a growth rate of 88%. Growth is 76%, adjusted for currency effects. Organic growth adjusted for license revenues in the first quarter from Selecta Biosciences is 41%, and 30% when also adjusted for currency effects .....
Rigtigt godt regnskab fra Genovis.
Luk i kurs 49,15 & +13,12%
https://mb.cision.com/Main/1712/3820614/2247306.pdf
https://news.cision.com/genovis-ab/r/half-yearly-report-january-june-2023,c3820614
Continued strong growth in both enzyme and antibody business
January - June 2023
Net sales totaled SEK 100,739 (53,667) thousand, with a growth rate of 88%. Growth is 76%, adjusted for currency effects. Organic growth adjusted for license revenues in the first quarter from Selecta Biosciences is 41%, and 30% when also adjusted for currency effects .....
Rigtigt godt regnskab fra Genovis.
Luk i kurs 49,15 & +13,12%
Ja man kan vil ikke klage over dette flotte regnskab. Fremtiden ser lovende ud?. Haft aktien siden 2007.
